ReviewClinical pharmacology : advances and applications2014

Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens.

Tetsuya MatsumotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.